Meet with… Mercury Fund

Add this event to your calendar:
16/11/2017 11:30 16/11/2017 14:00 America/Chicago Meet with… Mercury Fund JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021 JLABS @ TMC false DD/MM/YYYY
November
16
Event

Meet with… Mercury Fund

JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021

November 16, 2017 from 11:30 AM to 14:00 PM (CST)

$10 - $35


On November 16th, Mercury Fund will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.

Mercury Fund is an early-stage venture capital firm. With over $200 million under management, Mercury focuses on entrepreneurs and technology innovation originating in the U.S. Midcontinent. Our investment themes target SaaS, Cloud, and Data Science/AI platforms that make the industrial ecosystems of Middle America more competitive and efficient.

Over a decade ago, Mercury recognized the rise of entrepreneurs and innovation in the underinvested Midcontinent. Our venture investment strategy leverages our unparalleled network of midcontinent startup development organizations, corporate innovation partners, and co-investors to assist entrepreneurs with the resources they need to rapidly scale their businesses. We have spent our professional careers advising, mentoring, and investing in Mid-American entrepreneurs. We believe now, more than ever, the Midcontinent represents a great venture capital opportunity.

Agenda:
10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
1:00-5:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on October 31st. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on November 14th (or sold out). 

Texas Halo Fund Participating Representatives:

Dan Watkins | Co-founder & Partner, Mercury Fund

Dan Watkins is a co-founder and Partner at Mercury, where he focuses on startups utilizing software, cloud computing and/or machine learning to drive the next wave of scientific innovation in healthcare, agriculture and other industrial markets. Dan currently serves on the boards of Mercury portfolio companies Benson Hill, Clean Chemistry, Deep Imaging, DNAtrix, Resonant, Sight Machine (observer), Sinopsys, and Swift Bioscience. Dan’s previous investments at Mercury have included Cgate Health (acq. By SCI Solutions).

Prior to co-founding Mercury, Dan served in a number of operational roles including CEO of DNAtrix and Nanospectra Biosciences, both startup oncology companies. Previously, Dan was Vice President at a boutique investment banking firm and Worldwide Manager of Operations and Control Systems for Scientific Software-Intercomp (Baker Hughes). Dan received his B.S. from Rice University and his M.S. and Ph.D. from Carnegie Mellon University, all in Materials Science.

Dan is also a co-founder of the Rice Alliance for Technology and Entrepreneurship at Rice University. Outside of Mercury, Dan serves on the advisory boards of Northwestern University’s Innovation and New Venture Office (INVO), the Rice Alliance, the University of Michigan’s Venture Center Council, and the University of Illinois Proof of Concept Fund Committee.

 

Fees:

Presentation & Lunch
$25 | General Public
$35 | Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on November 13th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies

Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on October 31st. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of one-on-one meetings is not guaranteed as all applications must be approved.

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCATS, NINDS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.

Location:
JLABS @ TMC
John P. McGovern Campus
2450 Holcombe Blvd, Suite J
Houston, TX 77021

Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.
TMC Map


JLABS @ TMC

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

Event contact


Related content